The successful treatment of microscopic polyangiitis associated with non-tuberculous mycobacterial-pulmonary disease

被引:0
|
作者
Yoshii, Ryuichi [1 ]
Kajiwara, Kengo [1 ]
Uemura, Naomichi [1 ]
Matsushita, Koki [1 ]
Nakamura, Tomohumi [1 ]
Tomita, Masao [1 ]
Mukoyama, Masashi [2 ]
机构
[1] NHO, Kumamoto Med Ctr, 1-5 Ninomaru, Kumamoto 8600008, Japan
[2] Kumamoto Univ Hosp, 1-1-1 Honjo, Kumamoto, Kumamoto, Japan
关键词
Microscopic polyangiitis; Non-tuberculous mycobacterial-pulmonary disease; Non-tuberculous mycobacteria; Rituximab; Plasmapheresis; CYCLOPHOSPHAMIDE; INFECTION; RITUXIMAB;
D O I
10.1007/s13730-023-00839-x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
While the incidence and prevalence of non-tuberculous mycobacterial-pulmonary disease (NTM-PD) are increasing and microscopic polyangiitis (MPA) is common in East Asian countries, case reports of MPA associated with NTM-PD are limited. A 72-year-old male receiving treatment for NTM-PD with antibiotics was referred to our hospital with fever and arthralgia that developed a few months previously. A blood test revealed the presence of the myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA) and renal impairment. Based on a pathological examination of renal tissue, which showed crescentic glomerulonephritis, the patient was diagnosed with MPA. Due to acute kidney injury and strongly positive MPO-ANCA, pulse steroid therapy was initiated followed by intravenous rituximab (RTX). The patient also received plasmapheresis (14 sessions). Renal dysfunction was reversed. MPA associated with NTM-PD is extremely rare and, thus, there is currently no established treatment. Our patient was diagnosed with MPA based on the findings of renal biopsy while receiving treatment for NTM-PD. RTX and plasmapheresis combined with systemic glucocorticoid therapy were initiated before these clinical conditions had fully recovered. Although MPA secondary to NTM-PD may be more refractory to treatment than primary MPA in the presence of a very low interferon-gamma (IFN-gamma) level, this case was successfully treated with steroids, RTX, and plasmapheresis.
引用
收藏
页码:271 / 276
页数:6
相关论文
共 50 条
  • [21] Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease
    Kumar, Kartik
    Kon, Onn Min
    MICROORGANISMS, 2021, 9 (11)
  • [22] Mortality and causes of death in non-tuberculous mycobacterial pulmonary disease
    Pedersen, A. A.
    Dahl, V. N.
    Lokke, A.
    Holden, I. K.
    Floe, A.
    Ibsen, R.
    Johansen, I. S.
    Hilberg, O.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2025, 29 (02)
  • [23] NON-TUBERCULOUS MYCOBACTERIAL PULMONARY DISEASE: AN ITALIAN NATIONAL SURVEY
    Del Prato, Bruno
    Altieri, Alfonso Maria
    Carlucci, Biagio
    Mori, Pier Anselmo
    Parrella, Roberto
    Stainer, Anna
    De Giacomi, Federica
    Pesci, Alberto
    Faverio, Paola
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2018, 35 (01) : 21 - 25
  • [24] Incidence and associated risk factors of non-tuberculous mycobacterial pulmonary disease in patients with depression
    Ryu, Woo Kyung
    Lee, Jakyung
    Park, Youngmok
    Jung, Inkyung
    Kang, Young Ae
    RESPIROLOGY, 2023, 28 : 238 - 238
  • [25] Factors Associated With Lung Function Decline In Patients With Non-Tuberculous Mycobacterial Pulmonary Disease
    Chang, K.
    Lee, M. -R.
    Yang, C. -Y.
    Keng, L. -T.
    Yen, D. H.
    Wang, J. -Y.
    Wu, H. -D.
    Lee, L. -N.
    Yu, C. -J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [26] Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease
    Lee, Meng-Rui
    Yang, Ching-Yao
    Chang, Kai-Ping
    Keng, Li-Ta
    Yen, David Hung-Tsang
    Wang, Jann-Yuan
    Wu, Huey-Dong
    Lee, Li-Na
    Yu, Chong-Jen
    PLOS ONE, 2013, 8 (03):
  • [27] NON-TUBERCULOUS MYCOBACTERIAL DISEASE IN CHILDREN
    ROURK, MH
    HERROD, HG
    SPOCK, A
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1979, 119 (04): : 409 - 409
  • [28] Immunodeficiency in non-tuberculous mycobacterial disease
    Froebel, KS
    Bollert, FGE
    Jellema, J
    Bird, AG
    Greening, AP
    RESPIRATORY MEDICINE, 1997, 91 (02) : 95 - 101
  • [29] Nationwide evaluation of treatment outcomes and survival of patients with non-tuberculous mycobacterial pulmonary disease
    Makek, M. J.
    Glodic, G.
    Sabol, I.
    Zmak, L.
    Samarzija, M.
    Sola, A.
    Marusic, A.
    Marekovic, I.
    Bulat, L. K.
    Corak, L.
    Obrovac, M.
    van Ingen, J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2024, 28 (10)
  • [30] Pulmonary Non-tuberculous Mycobacterial Colonization Versus Disease Diagnosed During Tuberculosis Treatment
    Ganninger, A.
    Goldstein, D.
    Kumar, K.
    Bennett, S. Cooper
    Robinson, C.
    Fennelly, K. P.
    Anidi, I. U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209